Glyco-biomarkers: Potential determinants of cellular physiology and pathology

Disease Markers

Volumn 25, Issue 4-5, 2008, Pages 193-205

  Alavi, Azita ^a   Axford, John S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmunity; Glyco biomarkers; Glyco antigens; Glycomics; Glycosylation; Immunoglobulin G; Rheumatoid arthritis; Sugar printing

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLYCAN; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; RHEUMATOID FACTOR; TN ANTIGEN;

ANAPHYLACTOID PURPURA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DAMAGE; CELL FUNCTION; CROHN DISEASE; ENTERITIS; GLYCOSYLATION; HUMAN; MULTIPLE SCLEROSIS; NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 58149387521     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/863032     Document Type: Review

References (107)

1. P.M. Rudd, T. Elliott, P. Cresswell, I.A. Wilson and R.A. Dwek, Glycosylation and the immune system, Science 291(5512) (2001), 2370-2376.
2. J. Axford, The impact of glycobiology on medicine, Trends Immunol 22(5) (2001), 237-239.
3. A. Alavi and J.S. Axford, The pivotal nature of sugars in normal physiology and disease, Wien Med Wochenschr 156(1-2) (2006), 19-33.
4. J.S.E. Axford, ed., Glycobiology and Medicine, Proceedings of the 7th Jenner Glycobiology and Medicine Symposium, Springer, 2005.
5. B.A. Cobb and D.L. Kasper, Coming of age: carbohydrates and immunity, Eur J Immunol 35(2) (2005), 352-356.
6. N.H. Packer, C.W. von der Lieth, K.F. Aoki-Kinoshita, C.B. Lebrilla, J.C. Paulson, R. Raman et al., Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006), Proteomics 8(1) (2008), 8-20.
7. A. Varki, Nothing in glycobiology makes sense, except in the light of evolution, Cell 126(5) (2006), 841-845.
8. H.J. Gabius, Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer, Crit Rev Immunol 26(1) (2006), 43-79.
9. E.I. Buzas, B. Gyorgy, M. Pasztoi, I. Jelinek, A. Falus and H.J. Gabius, Carbohydrate recognition systems in autoimmunity, Autoimmunity 39(8) (2006), 691-704.
10. J.D. Hernandez, J.T. Nguyen, J. He, W. Wang, B. Ardman, J.M. Green et al., Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death, J Immunol 177(8) (2006), 5328-5336.
11. S. Nakahara and A. Raz, Biological modulation by lectins and their ligands in tumor progression and metastasis, Anticancer Agents Med Chem 8(1) (2008), 22-36.
12. P.R. Crocker, J.C. Paulson and A. Varki, Siglecs and their Roles in the Immune System 7(4) (2007), 255-266.
13. E.M. Egorina, M.A. Sovershaev and B. Osterud, Regulation of tissue factor procoagulant activity by post-translational modifications, Thromb Res, 2008.
14. V. Ilic, N. Milosevic-Jovcic, S. Petrovic, D. Markovic, G. Stefanovic and T. Ristic, Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR, Glycoconj J, 2008.
15. J. Meng, P. Parroche, D.T. Golenbock and C.J. McKnight, The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14, J Biol Chem 283(6) (2008), 3376-3384.
16. X. Yang, J. Yip, M. Harrison and I. Brockhausen, Primary human osteoblasts and bone cancer cells as models to study glycodynamics in bone, Int J Biochem Cell Biol 40(3) (2008), 471-483.
17. A. Golks, T.T. Tran, J.F. Goetschy and D. Guerini, Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation, Embo J 26(20) (2007), 4368-4379.
18. M.A. Toscano, G.A. Bianco, J.M. Ilarregui, D.O. Croci, J. Correale, J.D. Hernandez et al., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death, Nat Immunol 8(8) (2007), 825-834.
19. J. Jenner, G. Kerst, R. Handgretinger and I. Muller, Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells, Exp Hematol 34(9) (2006), 1212-1218.
20. L. Medvedova and R. Farkas, Hormonal control of protein glycosylation: role of steroids and related lipophilic ligands, Endocr Regul 38(2) (2004), 65-79.
21. A. Alavi and J. Axford, The Glycosyltransferases, in: Abnormalities of IgG Glycosylation and Immunological Disorders, D. Isenberg, Radmaecher, eds, 1996, pp. 149-169.
22. K.S. Lau, E.A. Partridge, A. Grigorian, C.I. Silvescu, V.N. Reinhold, M. Demetriou et al., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation, Cell 129(1) (2007), 123-134.
23. V.S. Sarafian and T.T. Marinova, ABH histo-blood group antigens in human thymus involution, Arch Med Res 37(7) (2006), 844-847.
24. K.S. Nandakumar, M. Collin, A. Olsen, F. Nimmerjahn, A.M. Blom, J.V. Ravetch et al., Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis, Eur J Immunol 37(10) (2007), 2973-2982.
25. J.J. Caramelo and A.J. Parodi, How sugars convey information on protein conformation in the endoplasmic reticulum, Semin Cell Dev Biol 18(6) (2007), 732-742.
26. M. Aridor, Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases, Adv Drug Deliv Rev 59(8) (2007), 759-781.
27. O. Vagin, S. Turdikulova and E. Tokhtaeva, Polarized membrane distribution of potassium-dependent ion pumps in epithelial cells: different roles of the N-glycans of their beta subunits, Cell Biochem Biophys 47(3) (2007), 376-391.
28. R. Stork, K.A. Zettlitz, D. Muller, M. Rether, F.G. Hanisch and R.E. Kontermann, N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies, J Biol Chem, 2008.
29. Y. Li, B. Cleveland, I. Klots, B. Travis, B.A. Richardson, D. Anderson et al., Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses, J Virol 82(2) (2008), 638-651.
30. G. Opdenakker, C. Dillen, P. Fiten, E. Martens, I. van Aelst, P.E. van den Steen et al., Remnant epitopes, autoimmunity and glycosylation, Biochim Biophys Acta 1760(4) (2006), 610-615.
31. G.A. Rabinovich, M.A. Toscano, S.S. Jackson and G.R. Vasta, Functions of cell surface galectin-glycoprotein lattices, Curr Opin Struct Biol 17(5) (2007), 513-520.
32. M.V. Tribulatti, J. Mucci, V. Cattaneo, F. Aguero, T. Gilmartin, S.R. Head et al., Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation, Glycobiology 17(12) (2007), 1404-1412.
33. F. Nimmerjahn and J.V. Ravetch, Fc-receptors as regulators of immunity, Adv Immunol 96 (2007), 179-204.
34. M. Bax, J.J. Garcia-Vallejo, J. Jang-Lee, S.J. North, T.J. Gilmartin, G. Hernandez et al., Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins, J Immunol 179(12) (2007), 8216-8224.
35. E. Balcan, I. Tuglu, M. Sahin and P. Toparlak, Cell surface glycosylation diversity of embryonic thymic tissues, Acta Histochem 110(1) (2008), 14-25.
36. O. Vagin, E. Tokhtaeva, I. Yakubov, E. Shevchenko and G. Sachs, Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia, Contribution of the Na,K-ATPase beta1 subunit, J Biol Chem 283(4) (2008), 2192-2202.
37. J.L. Miller, B.J. Dewet, L. Martinez-Pomares, C.M. Radcliffe, R.A. Dwek, P.M. Rudd et al., The Mannose Receptor Mediates Dengue Virus Infection of Macrophages, PLoS Pathog 4(2) (2008), e17.
38. C. Sugimoto, E.E. Nakayama, T. Shioda, F. Villinger, A.A. Ansari, N. Yamamoto et al., Impact of glycosylation on anti-genicity of simian immunodeficiency virus SIV239: induction of rapid V1/V2-specific non-neutralizing antibody and delayed neutralizing antibody following infection with an attenuated deglycosylated mutant, J Gen Virol 89(Pt 2) (2008), 554-566.
39. S. Fauquenoy, W. Morelle, A. Hovasse, A. Bednarczyk, C. Slomianny, C. Schaeffer et al., Proteomic and glycomic analyses of N-glycosylated structures involved in toxoplasma gondii-host cell interactions, Mol Cell Proteomics, 2008.
40. S. Groux-Degroote, M.A. Krzewinski-Recchi, A. Cazet, A. Vincent, S. Lehoux, J.J. Lafitte et al., IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa, Biochem J 410(1) (2008), 213-223.
41. G. Garratty, Blood groups and disease: a historical perspective, Transfus Med Rev 14(4) (2000), 291-301.
42. M. Tan and X. Jiang, Norovirus-host interaction: implications for disease control and prevention, Expert Rev Mol Med 9(19) (2007), 1-22.
43. L.C. Lindesmith, E.F. Donaldson, A.D. Lobue, J.L. Cannon, D.P. Zheng, J. Vinje et al., Mechanisms of GII.4 norovirus persistence in human populations, PLoS Med 5(2) (2008), e31.
44. S. Linden, J. Mahdavi, C. Semino-Mora, C. Olsen, I. Carlstedt, T. Boren et al., Role of ABO secretor status in mucosal innate immunity and H. pylori infection, PLoS Pathog 4(1) (2008), e2.
45. M.P. Loscertales, S. Owens, J. O'Donnell, J. Bunn, X. Bosch-Capblanch and B.J. Brabin, ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism, Adv Parasitol 65 (2007), 1-50.
46. O. Wu, N. Bayoumi, M.A. Vickers and P. Clark, ABO(H) blood groups and vascular disease: a systematic review and meta-analysis, J Thromb Haemost 6(1) (2008), 62-69.
47. E. Dabelsteen and S. Gao, ABO blood-group antigens in oral cancer, J Dent Res 84(1) (2005), 21-28.
48. S. Marionneau, A. Cailleau-Thomas, J. Rocher, B. Le Moullac-Vaidye, N. Ruvoen, M. Clement et al., ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world, Biochimie 83(7) (2001), 565-573.
49. J.C. Chatham, L.G. Not, N. Fulop and R.B. Marchase, Hexosamine Biosynthesis and Protein O-Glycosylation: The First Line of Defense against Stress, Ischemia, and Trauma, Shock, 2007.
50. J.E. Rexach, P.M. Clark and L.C. Hsieh-Wilson, Chemical approaches to understanding O-GlcNAc glycosylation in the brain, Nat Chem Biol 4(2) (2008), 97-106.
51. R. Morgan, G. Gao, J. Pawling, J.W. Dennis, M. Demetriou and B. Li, N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells, J Immunol 173(12) (2004), 7200-7208.
52. V. Vanhooren, L. Desmyter, X.E. Liu, M. Cardelli, C. Franceschi, A. Federico et al., N-glycomic changes in serum proteins during human aging, Rejuvenation Res 10(4) (2007), 521-531a.
53. P. Cheung, J. Pawling, E.A. Partridge, B. Sukhu, M. Grynpas and J.W. Dennis, Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans, Glycobiology 17(8) (2007), 828-837.
54. S.A. Brooks, T.M. Carter, L. Royle, D.J. Harvey, S.A. Fry, C. Kinch et al., Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies, Anticancer Agents Med Chem 8(1) (2008), 2-21.
55. M. Watson, P.M. Rudd, M. Bland, R.A. Dwek and J.S. Axford, Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides, Arthritis Rheum 42(8) (1999), 1682-1690.
56. K. Martin, R. Talukder, F.C. Hay and J.S. Axford, Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis, J Rheumatol 28(7) (2001), 1531-1536.
57. J.S. Axford, G. Cunnane, O. Fitzgerald, J.M. Bland, B. Bresnihan and E.R. Frears, Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis, J Rheumatol 30(12) (2003), 2540-2546.
58. A. Alavi and J. Axford, Sweet & Sour: The impact of sugars on disease, Rheumatol, In Press, 2008.
59. L.J. Marshall, B. Perks, K. Bodey, R. Suri, A. Bush and J.K. Shute, Free secretory component from cystic fibrosis sputa displays the cystic fibrosis glycosylation phenotype, Am J Respir Crit Care Med 169(3) (2004), 399-406.
60. V.A. Lawson, S.J. Collins, C.L. Masters and A.F. Hill, Prion protein glycosylation, J Neurochem 93(4) (2005), 793-801.
61. T. Lefebvre, C. Guinez, V. Dehennaut, O. Beseme-Dekeyser, W. Morelle and J.C. Michalski, Does O-GlcNAc play a role in neurodegenerative diseases? Expert Rev Proteomics 2(2) (2005), 265-275.
62. P.T. Martin, Congenital muscular dystrophies involving the O-mannose pathway, Curr Mol Med 7(4) (2007), 417-425.
63. R.S. Bakri, B. Afzali, A. Covic, R. Sriskantharan, P. Bharma-Ariza, W.H. Park et al., Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation, Clin Transplant 18(2) (2004), 201-204.
64. N. Fulop, R.B. Marchase and J.C. Chatham, Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system, Cardiovasc Res 73(2) (2007), 288-297.
65. K. Bodger, J. Halfvarson, A.R. Dodson, F. Campbell, S. Wilson, R. Lee et al., Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients, Gut 55(7) (2006), 973-977.
66. J. Novak, B.A. Julian, M. Tomana and J. Mestecky, IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy, Semin Nephrol 28(1) (2008), 78-87.
67. A.G. Gharavi, Z. Moldoveanu, R.J. Wyatt, C.V. Barker, S.Y. Woodford, R.P. Lifton et al., Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy, J Am Soc Nephrol, 2008.
68. K.S. Weber, R. Alon and L.B. Klickstein, Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN, Inflammation 28(4) (2004), 177-188.
69. C. Willyard, Researchers look for 'sweet' method to diagnose cancer, Nat Med 13(11) (2007), 1267.
70. Y. Qiu, T.H. Patwa, L. Xu, K. Shedden, D.E. Misek, M. Tuck et al., Plasma Glycoprotein Profiling for Colorectal Cancer Biomarker Identification by Lectin Glycoarray and Lectin Blot, J Proteome Res, 2008.
71. S.J. Storr, L. Royle, C.J. Chapman, U.M. Hamid, J.F. Robertson, A. Murray et al., The O-linked glycosylation of secretory/shed MUC1 from advanced breast cancer patient serum, Glycobiology, 2008.
72. J. Jaeken and G. Matthijs, Congenital disorders of glycosylation: a rapidly expanding disease family, Annu Rev Genomics Hum Genet 8 (2007), 261-278.
73. T. Okanishi, Y. Saito, I. Yuasa, M. Miura, I. Nagata, Y. Maegaki et al., Cutis laxa with frontoparietal cortical malformation: A novel type of congenital disorder of glycosylation, Eur J Paediatr Neurol, 2008.
74. C. Perez-Cerda, D. Quelhas, A.I. Vega, J. Ecay, L. Vilarinho and M. Ugarte, Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease, Clin Chem 54(1) (2008), 93-100.
75. J. Gu and M. Taniguchi, Regulation of integrin functions by N-glycans, Glycoconj J 21(1-2) (2004), 9-15.
76. L.B. Lowe, Glycosylation in the control of selectin counter-receptor structure and function, Immunol Rev 86 (2002), 19-36.
77. M. Kilcoyne and L. Joshi, Carbohydrates in therapeutics, Cardiovasc Hematol Agents Med Chem 5(3) (2007), 186-197.
78. M. Tatsumoto, M. Koga, M. Gilbert, M. Odaka, K. Hirata, S. Kuwabara et al., Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a, J Neuroimmunol 177(1-2) (2006), 201-208.
79. D. Chui, G. Sellakumar, R. Green, M. Sutton-Smith, T. McQuistan, K. Marek et al., Genetic remodeling of protein glycosylation in vivo induces autoimmune disease, Proc Natl Acad Sci USA 98(3) (2001), 1142-1147.
80. H.A. Doyle and M.J. Mamula, Post-translational protein modifications in antigen recognition and autoimmunity, Trends Immunol 22(8) (2001), 443-439.
81. F. Altmann, The role of protein glycosylation in allergy, Int Arch Allergy Immunol 142(2) (2007), 99-115.
82. D. Wu, M. Fujio and C.H. Wong, Glycolipids as immunostimulating agents, Bioorg Med Chem 16(3) (2008), 1073-1083.
83. I. Dotan, S. Fishman, Y. Dgani, M. Schwartz, A. Karban, A. Lerner et al., Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease, Gastroenterology 131(2) (2006), 366-378.
84. D.H. Dube and C.R. Bertozzi, Glycans in cancer and inflammation-potential for therapeutics and diagnostics, Nat Rev Drug Discov 4(6) (2005), 477-488.
85. M. Bardor, D.H. Nguyen, S. Diaz and A. Varki, Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells, J Biol Chem 280(6) (2005), 4228-4237.
86. R. Parekh, D. Isenberg, G. Rook, I. Roitt, R. Dwek and T. Rademacher, A comparative analysis of disease-associated changes in the galactosylation of serum IgG, J Autoimmun 2(2) (1989), 101-114.
87. Y. Kaneko, F. Nimmerjahn and J.V. Ravetch, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science 313(5787) (2006), 670-673.
88. R. Jefferis, Antibody therapeutics: isotype and glycoform selection, Expert Opin Biol Ther 7(9) (2007), 1401-1413.
89. J.S. Axford, L. Mackenzie, P.M. Lydyard, F.C. Hay, D.A. Isenberg and I.M. Roitt, Reduced B-cell galactosyltransferase activity in rheumatoid arthritis, Lancet 2(8574) (1987), 1486-1488.
90. J.S. Axford, N. Sumar, A. Alavi, D.A. Isenberg, A. Young, K.B. Bodman et al., Changes in normal glycosylation mechanisms in autoimmune rheumatic disease, J Clin Invest 89(3) (1992), 1021-1031.
91. A. Alavi, N. Arden, T.D. Spector and J.S. Axford, Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy, J Rheumatol 27(6) (2000), 1379-1385.
92. A. Matsumoto, K. Shikata, F. Takeuchi, N. Kojima and T. Mizuochi, Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation, J Biochem (Tokyo) 128(4) (2000), 621-628.
93. C.T. Chou, Binding of rheumatoid and lupus synovial fluids and sera-derived human IgG rheumatoid factor to degalactosylated IgG, Arch Med Res 33(6) (2002), 541-544.
94. A. Alavi, J.S. Axford and A.J. Pool, Serum galactosyltransferase isoform changes in rheumatoid arthritis, J Rheumatol 31(8) (2004), 1513-1520.
95. K. Masuda, Y. Yamaguchi, K. Kato, N. Takahashi, I. Shimada and Y. Arata, Pairing of oligosaccharides in the Fc region of immunoglobulin G, FEBS Lett 473(3) (2000), 349-357.
96. Y. Kuroda, M. Nakata, A. Makino, A. Matsumoto, K. Ohashi, K. Itahashi et al., Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome, Glycoconj J 19(1) (2002), 23-31.
97. H. Das, T. Atsumi, Y. Fukushima, H. Shibuya, K. Ito, Y. Yamada et al., Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis, Clin Rheumatol 23(3) (2004), 218-222.
98. D. van Zeben, G.A. Rook, J.M. Hazes, A.H. Zwinderman, Y. Zhang, S. Ghelani et al., Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study, Br J Rheumatol 33(1) (1994), 36-43.
99. E. Gindzienska-Sieskiewicz, P.A. Klimiuk, D.G. Kisiel, A. Gindzienski and S. Sierakowski, The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis, Clin Rheumatol 2006.
100. M. Pasek, M. Duk, M. Podbielska, R. Sokolik, J. Szechinski, E. Lisowska et al., Galactosylation of IgG from rheumatoid arthritis (RA) patients - changes during therapy, Glycoconj J 23(7-8) (2006), 463-471.
101. B.D. Oortwijn, A. Roos, L. Royle, D.J. van Gijlswijk-Janssen, M.C. Faber-Krol, J.W. Eijgenraam et al., Differential Glycosylation of Polymeric and Monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy, J Am Soc Nephrol, 2006.
102. B.J. Campbell, L.G. Yu and J.M. Rhodes, Altered glycosylation in inflammatory bowel disease: a possible role in cancer development, Glycoconj J 18(11-12) (2001), 851-858.
103. N. Maeno, S. Takei, S. Fujikawa, Y. Yamada, H. Imanaka, M. Hokonohara et al., Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjogren's syndrome, and healthy children, J Rheumatol 31(6) (2004), 1211-1217.
104. M.H. Ravindranath, S. Muthugounder, T.S. Saravanan, N. Presser and D.L. Morton, Human antiganglioside autoantibodies: validation of ELISA, Ann N Y Acad Sci 1050 (2005), 229-242.
105. K. Kaida, S. Kusunoki, K. Kamakura, K. Motoyoshi and I. Kanazawa, GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody, Neurology 61(4) (2003), 465-470.
106. M.L. Kuijf, P.C. Godschalk, M. Gilbert, H.P. Endtz, A.P. Tio-Gillen, C.W. Ang et al., Origin of ganglioside complex antibodies in Guillain-Barre syndrome, J Neuroimmunol 188(1-2) (2007), 69-73.
107. O.O. Blumenfeld, P. Lalezari, M. Khorshidi, K. Puglia and M. Fukuda, O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome, Blood 80(9) (1992), 2388-2395.